A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity

Key Inclusion Criteria:

• Participants 18 years of age or older
• BMI of 27-45 kg/m2; and a total body weight >50 kg (110 lb)

Key Exclusion Criteria:

• Pregnant or breastfeeding women, or those planning pregnancy during the study
• History of other chronic disorders
• Personal or first-degree family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2), or suspected MTC
• Clinically significant gastric emptying abnormality or chronically taking drugs that directly affect gastrointestinal (GI) motility
• Acute GI symptoms at screening, Day -1, or prior to administration of study intervention